ArticleFrontiers in oncology2025

Efficacy and safety of transarterial chemoembolization combined with sintilimab and bevacizumab in hepatocellular carcinoma.

Yi Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.